CBD Global Sciences announced this week that it has begun the process to formally change its name from “CBD Global Sciences” to “Global Sciences Inc.,” dropping CBD from its name.
The company has begun to operate under the trade name “Global Sciences” until it has full shareholder and regulatory approval. This move comes with the opportunity to expand the company’s focus to more than just CBD with recently discovered opportunities that it believes will create value for its shareholders.
The name change will not impact Global Science’s ability to increase revenues and profitability within the CBD and distribution industries. The change will enhance Global Science’s ability to better define itself as it explores other areas in the field of wellness sciences.
The company will roll out its new website in the next week and can be found at www.globalsciences.com. When approved, the company’s trading symbol will change accordingly.
“In the ever-changing industry of CBD the team at Global Sciences has become accustomed to quickly pivoting to provide better value to its customers and shareholders,” said CBD Global Sciences CEO Brad Wyatt. “This change is the beginning of more exciting news that will be presented in the near term. We are still very active in the CBD landscape and presenting wins for our company with lower cost manufacturing and more points of distribution, which will translate into increased revenues and improved profitability. We are very excited about 2022 and beyond for our company and its shareholders.”
Global Sciences Inc. is a hemp-based CBD producer and branding investment vehicle which currently owns multiple brands like the name Aethics and Cannaoil, which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, hydration products and confectionary products.
Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers and online.
